ZIMBERELIMAB: 193 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
193
Total FAERS Reports
62 (32.1%)
Deaths Reported
181
Hospitalizations
193
As Primary/Secondary Suspect
40
Life-Threatening
First Report: 20210701 · Latest Report: 20241028
What Are the Most Common ZIMBERELIMAB Side Effects?
#1 Most Reported
Febrile neutropenia
36 reports (18.7%)
#2 Most Reported
Vomiting
34 reports (17.6%)
#3 Most Reported
Dysphagia
30 reports (15.5%)
All ZIMBERELIMAB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 36 | 18.7% | 21 | 34 |
| Vomiting | 34 | 17.6% | 9 | 33 |
| Dysphagia | 30 | 15.5% | 5 | 29 |
| Nausea | 29 | 15.0% | 8 | 28 |
| Fatigue | 27 | 14.0% | 1 | 27 |
| Platelet count decreased | 25 | 13.0% | 13 | 23 |
| Diarrhoea | 23 | 11.9% | 4 | 22 |
| Disease progression | 20 | 10.4% | 20 | 20 |
| Pyrexia | 20 | 10.4% | 2 | 20 |
| Asthenia | 16 | 8.3% | 9 | 15 |
| Respiratory tract infection | 15 | 7.8% | 0 | 15 |
| Neutropenia | 14 | 7.3% | 5 | 13 |
| Hyponatraemia | 13 | 6.7% | 9 | 13 |
| Drug hypersensitivity | 12 | 6.2% | 9 | 12 |
| Thrombocytopenia | 12 | 6.2% | 7 | 11 |
| Gastrointestinal haemorrhage | 11 | 5.7% | 10 | 11 |
| White blood cell count decreased | 11 | 5.7% | 2 | 9 |
| Off label use | 10 | 5.2% | 2 | 9 |
| Respiratory failure | 10 | 5.2% | 10 | 10 |
| Anaemia | 9 | 4.7% | 4 | 7 |
Who Reports ZIMBERELIMAB Side Effects? Age & Gender Data
Gender: 48.3% female, 51.7% male. Average age: 63.6 years. Most reports from: ES. View detailed demographics →
Is ZIMBERELIMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2021 | 7 | 1 | 6 |
| 2022 | 69 | 28 | 66 |
| 2023 | 52 | 8 | 52 |
| 2024 | 57 | 24 | 55 |
What Is ZIMBERELIMAB Used For?
| Indication | Reports |
|---|---|
| Non-small cell lung cancer metastatic | 85 |
| Colorectal cancer | 71 |
| Gastric cancer | 7 |
| Colorectal cancer metastatic | 5 |
| Non-small cell lung cancer | 5 |
ZIMBERELIMAB vs Alternatives: Which Is Safer?
ZIMBERELIMAB vs ZINC
ZIMBERELIMAB vs ZINC\ZINC
ZIMBERELIMAB vs ZIPRASIDONE
ZIMBERELIMAB vs ZIPRASIDONE\ZIPRASIDONE
ZIMBERELIMAB vs ZITHROMAX
ZIMBERELIMAB vs ZIV-AFLIBERCEPT
ZIMBERELIMAB vs ZOCOR
ZIMBERELIMAB vs ZOFENOPRIL
ZIMBERELIMAB vs ZOFRAN
ZIMBERELIMAB vs ZOLADEX
Official FDA Label for ZIMBERELIMAB
Official prescribing information from the FDA-approved drug label.